Sera Prognostics, Inc. (SERA) Financials

SERA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 93.5 million 25.9 million
Dec. 31, 2025 101.9 million 26.5 million
Sept. 30, 2025 108.1 million 25.9 million
June 30, 2025 111.8 million 23.6 million

SERA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.8 million 835000
Dec. 31, 2025 -6.5 million 1.0 million
Sept. 30, 2025 -6.6 million 1.3 million
June 30, 2025 -5.8 million 1.3 million

SERA Net Income

No data available :(

SERA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 47.4 million 2.5 million -
Dec. 31, 2025 39.2 million 2.3 million 2.3 million
Sept. 30, 2025 43.3 million - 2.4 million
June 30, 2025 40.2 million - 351000

SERA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 50.3 million
Dec. 31, 2025 50.0 million
Sept. 30, 2025 49.5 million
June 30, 2025 49.1 million

SERA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 8000 3.0 million 6.3 million 2.0 million
Dec. 31, 2025 330000 3.2 million 5.7 million 1.7 million
Sept. 30, 2025 112000 3.3 million 5.7 million 1.6 million
June 30, 2025 281000 3.3 million 6.0 million 1.8 million

SERA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 14000 42000
Dec. 31, 2025 10000 42000
Sept. 30, 2025 16000 41000
June 30, 2025 17000 41000

SERA

Price: $1.75

52 week price:
1.37
4.09

Earnings Per Share: -0.64 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 1300

Market Capitalization: 85.7 million

Links: